Subclinical mycotoxin exposure is silent but costly. You may not see symptoms yet, but performance, fertility, immunity, and profitability are already under threat. Chronic low-level exposure, often deemed “safe”- can still trigger clinical symptoms and serious health issues. The Biomonitoring+ Program incorporates feed analysis and blood biomarker analysis (Myco-Marker™).

How Myco-Marker™ Analysis Works

Innovad Group has validated and patented a method to detect 36 different mycotoxin biomarkers in blood, including emerging mycotoxins, for a more comprehensive view of total risk. The Myco-Marker™ process is designed for practical on-farm use: one drop of blood is collected per animal using FTA cards, making sampling simple and allowing blood spots to be sent to the laboratory without special shipping restrictions.